CareDx stock climbs 7% amid reports Natera not pursuing litigation [Seeking Alpha]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Seeking Alpha
“With no claims of ongoing infringement, Natera ( NTRA ) cannot obtain an injunction on the current version of AlloSure Kidney,” Craig-Hallum said in a note Thursday, adding the news should be a “positive catalyst for CDNA shares as the Natera motion was seen by some as an overhang on the stock.” Shares of CareDx ( CDNA ) closed 12% lower on Wednesday. Craig-Hallum said it believed the drop was likely due to a large seller triggering quant selling. Also on Wednesday, CareDx ( CDNA ) said it had appointed Jing Huang as its chief data and artificial intelligence officer, a newly created position. Huang will lead data science initiatives that are a part of the company's long-term strategic growth plan, CareDx (CDNA) said in a statement On Tuesday, CareDx ( CDNA ) announced that the U.S. Department of Justice had closed an investigation into the company with no finding of wrongdoing. CareDx plans to present it long-term growth strategy during an Investor Day on October 15. Reco
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $26.00 to $35.00. They now have a "buy" rating on the stock.MarketBeat
- CareDx Reports Preliminary Financial Results for Third Quarter 2024Business Wire
- CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNAPR Newswire
- CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDx Appoints Jing Huang Chief Data and AI OfficerBusiness Wire
CDNA
Earnings
- 7/31/24 - Beat
CDNA
Sec Filings
- 10/17/24 - Form SC
- 10/15/24 - Form 8-K
- 10/8/24 - Form 4
- CDNA's page on the SEC website